Forest Looks To Licensing, Co-Promotion And Acquiring Products Going Forward To Boost Revenue
This article was originally published in The Pink Sheet Daily
Executive Summary
Upcoming patent expiration for the firm’s top drugs, combined with a modest pipeline, prompt the need to look outside.